ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,70%(-0,017) 1D
20-ноя., 17:29:34 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 миң
Volume
286,21 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 млн
Avg. vol.
785,30 миң
Volume
286,21 миң
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
AP News
·
1 күн мурун
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
24/7 Wall St.
·
1 саат мурун
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
The Motley Fool
·
11 саат мурун
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Beinsure
·
1 күн мурун
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com